【實用生活app】Psychopharmacology Update|最夯免費app-綠色工廠好玩App

Psychopharmacology Update features a licensed and Board Certified Psychiatric Pharmacist (BCPP) presenting an in-depth review over psychiatric medications that have recently been FDA approved. This presentation incorporates an audio-synced slide deck with easy to use functionality to improve the learning experience. This is a scholarly presentation that contains unbiased medication information (NO pharmaceutical sponsorship). PRESENTATION OBJECTIVES:Schizophrenia - describe how antipsychotics affect the pathophysiology of schizophrenia - identify basic dopamine pathways and their relationship with efficacy vs. side effects - discuss a unique treatment option for antipsychotic-induced hyperprolactinemia - examine pharmacological characteristics of 1st and 2nd generation antipsychotics - discuss differences between the newer antipsychotics - compare the mean increase in QTc prolongation for individual antipsychotics - review treatment goals, guidelines for selection, and monitoringDepression - discuss unique characteristics of vilazodone (Viibryd™) and vortioxetine (Brintellix™) - review medication selection - examine potential receptor targets - describe the mechanism of antidepressant-induced sexual dysfunction MEDICATIONS REVIEWED:Long-Acting Injectable Second Generation Antipsychotics - aripiprazole monohydrate (Abilify Maintena™) - olanzapine pamoate (Zyprexa® Relprevv™) - paliperidone palmitate (Invega® Sustenna®) - risperidone long-acting injectable (Risperdal® Consta®)Second Generation Antipsychotic Oral Formulations - iloperidone (Fanapt®) - asenapine (Saphris®) - lurasidone (Latuda®) First Generation Antipsychotic Inhalation Powder - loxapine inhalation powder (Adasuve®)Antidepressants - vilazodone (Viibryd™) - vortioxetine (Brintellix™)All aboard! Come take a journey through the wonderful world of psychopharmacology!!!